| |
| |
|
| Insider
Information: |
Belloff Neil S. |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
32,699 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,349 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
32,699 |
|
|
| Total
Value |
$26,349 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eloxx Pharmaceuticals Inc |
ELOX |
|
2021-07-30 |
32,699 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-07-30 |
4 |
D |
$1.32 |
$606 |
D/D |
(459) |
32,699 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
33,158 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-05-25 |
4 |
D |
$1.39 |
$2,551 |
D/D |
(1,835) |
31,595 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
33,430 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-04-30 |
4 |
D |
$2.18 |
$1,001 |
D/D |
(459) |
27,180 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
27,639 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-02-25 |
4 |
D |
$3.95 |
$28,985 |
D/D |
(7,338) |
26,077 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
33,415 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-01-30 |
4 |
D |
$3.44 |
$1,864 |
D/D |
(542) |
8,415 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2021-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
8,957 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-10-30 |
4 |
D |
$2.53 |
$1,161 |
D/D |
(459) |
7,394 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
7,853 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-07-30 |
4 |
D |
$2.84 |
$1,304 |
D/D |
(459) |
6,291 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
6,750 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-04-30 |
4 |
D |
$2.92 |
$1,340 |
D/D |
(459) |
5,187 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
COO, GENERAL COUNSEL &CORP SEC |
• – – |
2020-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
5,646 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
GENERAL COUNSEL/CORPORATE SECR |
• – – |
2020-01-30 |
4 |
D |
$3.91 |
$8,469 |
D/D |
(2,166) |
4,084 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
GENERAL COUNSEL/CORPORATE SECR |
• – – |
2020-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
